4//SEC Filing
Cahill Brian Joseph 4
Accession 0001209191-23-014650
CIK 0000827871other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 4:20 PM ET
Size
7.0 KB
Accession
0001209191-23-014650
Insider Transaction Report
Form 4
Cahill Brian Joseph
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2023-02-28$28.00/sh−718$20,104→ 29,368 total - Award
Common Stock
2023-03-01+18,500→ 47,868 total
Footnotes (2)
- [F1]The disposition reported on this Form 4 represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock units.
- [F2]Represents a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting of the unit. The shares issuable in respect of such RSUs shall vest with respect to 25% of the shares of common stock on each of the one, two, three and four-year anniversaries of March 1, 2023, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.
Documents
Issuer
EAGLE PHARMACEUTICALS, INC.
CIK 0000827871
Entity typeother
Related Parties
1- filerCIK 0001831591
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 4:20 PM ET
- Size
- 7.0 KB